Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00770770 · ClinicalTrials.gov registry record · Phase 2
Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina
A Phase 2 study, sponsored by Alimera Sciences.
- Terminated
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00770770: Clinical Trial Phase 2 study, sponsored by Alimera Sciences.
NCT00770770 is a Phase 2 study that was terminated before completion, run by Alimera Sciences. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00770770, a Phase 2 study, was terminated before completion, sponsored by Alimera Sciences.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will assess the safety and efficacy of FA Intravitreal Inserts in subjects with macular edema secondary to RVO.
Primary Outcome
To compare the 3 month best corrected visual acuity to baseline in subjects diagnosed with macular edema secondary to retinal vein occlusion. BCVA will be measured according to the standard procedure developed for ETDRS at 4 meters or 3 meters if the electronic (E)-ETDRS system is employed.
Interventions
- DRUG Fluocinolone Acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-05 |
| Phase | Phase 2 |
Why NCT00770770 stopped before completion
NCT00770770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Fluocinolone Acetonide is the first listed.
NCT00770770 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00770770 about?
NCT00770770 is a clinical study titled "Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina". This study will assess the safety and efficacy of FA Intravitreal Inserts in subjects with macular edema secondary to RVO.
What is the current status of trial NCT00770770?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2009-05.
What interventions are being tested in trial NCT00770770?
The interventions under investigation include: Fluocinolone Acetonide (DRUG).
Who is sponsoring clinical trial NCT00770770?
This trial is sponsored by Alimera Sciences, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00770770's enrollment target sits among peer trials
20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia